BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil-Reference-Cited by-同舟云学术

BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil

Published:2023-03-07 Issue:1 Volume:199 Page:127-136
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Mazzonetto Patricia,Milanezi Fernanda,D’Andrea Mariana,Martins Silvia,Monfredini Priscilla M.,dos Santos Silva Juliana,Perrone Eduardo,Villela Darine,Schnabel Beatriz,Nakano Viviane,Palmero Edenir Inez,Braggio Esteban,Cavalcanti Thereza L.,Guida Gustavo,Migliavacca Michele P.,Scapulatempo-Neto Cristovam,Zalcberg Ilana^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-023-06892-5.pdf

Reference32 articles.

1. Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4:665–676

2. Lakhani SR et al (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11:5175–5180

3. Turner N, Tutt A, Ashworth A (2004) Hallmarks of ‘BRCAness’ in sporadic cancers. Nat Rev Cancer 4:814–819

4. Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182

5. Lee A, Moon BI, Kim TH (2020) BRCA1/BRCA2 pathogenic variant breast cancer: treatment and prevention strategies. Ann Lab Med 40:114–121

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario;European Journal of Medical Research;2024-03-20

2. BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients;BMC Medical Genomics;2024-01-02